Acta Scientific Nutritional Health (ASNH)(ISSN: 2582-1423)

Review Article Volume 6 Issue 5

The Consumption of Omega-3 as Part of the Treatment and Prevention of Non-Alcoholic Fatty Liver Disease (NAFLD)

Jacqueline Valenzuela Rangel1*, Itzel Cabrera Yepez1 and Dra María Montserrat López Ortíz2

1Students of Nutrition at the Universidad de Guanajuato, Campus León, Mexico
2Researcher and full-time professor of the Department of Medicine and Nutrition at the Universidad de Guanajuato. Contact: Department of Medicine and Nutrition, Division of Health Sciences, Campus León. Universidad de Guanajuato, Mexico

*Corresponding Author: Jacqueline Valenzuela Rangel, Students of Nutrition at the Universidad de Guanajuato, Campus León, Mexico.

Received: March 16, 2022; Published: April 11, 2022

Abstract

It is common to hear about the liver, and how this organ can easily get sick or damaged by excessive alcohol consumption. However, there is a condition that is not necessarily related to alcohol intake, this is non-alcoholic fatty liver disease (NAFLD), and it can be prevented or modified in its early stages of evolution [1].

Keywords: Non-Alcoholic Fatty Liver Disease (NAFLD); Metabolic Syndrome; Hepatocyte; Omega-3:

References

  1. Janczyk W., et al. “Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial”. The Journal of Pediatrics 6 (2015): 1358-1363.
  2. Coronel E and Coronel M. “Esteatohepatitis no alcohólica (EHNA)”. Revista de Gastroenterología del Perú 1 (2016): 58-65.
  3. Castellanos L and Rodríguez M. “El efecto de Omega 3 en la salud humana y consideraciones en la ingesta”. Revista Chilena de Nutricion 1 (2015): 90-95.
  4. Secretaria de Salud, Instituto Nacional de Salud Pública. “Encuesta Nacional de Salud y Nutrición de Medio Camino 2016”. Informe Final de Resultados (2016).
  5. Bernal R., et al. “Consenso mexicano de la enfermedad por hígado graso no alcohólico”. Revista de Gastroenterología de México 1 (2019): 69-99.
  6. Hernández M., et al. “Beneficios de los ácidos grasos poliinsaturados de cadena larga n-3 en la enfermedad por hígado graso no alcohólico”. Revista Chilena de Nutrición 2 (2016): 196-205.
  7. Parker HM., et al. “Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis”. Journal of Hepatology 4 (2012): 944-951.
  8. Boyraz M., et al. “Long-Term Treatment with n-2 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease”. Journal of Clinical Research in Pediatric Endocrinology 2 (2015): 121-127.
  9. Aller R., et al. “Nutrición en el hígado graso no alcohólico”. Nutrition in Clinical Medicine2 (2019): 89-98.

Citation

Citation: Jacqueline Valenzuela Rangel., et al. “The Consumption of Omega-3 as Part of the Treatment and Prevention of Non-Alcoholic Fatty Liver Disease (NAFLD)". Acta Scientific Nutritional Health 6.5 (2022): 27-30.

Copyright

Copyright: © 2022 Jacqueline Valenzuela Rangel., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.316

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US